Published in AIDS Weekly, June 11th, 2001
L. Ratner and colleagues at Washington University in St. Louis, Missouri, compared the results of treatment with full and limited chemotherapy regimens in the context of highly active antiretroviral therapy (HAART).
Chemotherapy at both dose levels was effective and well tolerated, Ratner and team found although better results were seen with full-dose regimens.
Patients who received a scaled-down version of the CHOP...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.